Your trusted source for investing success
By Pia Rivera
Cypress Development Corp. (TSXV:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or the “Company”) is pleased to announce it has commenced drilling on its Clayton Valley Lithium Project, located just east of Albemarle’s Silver Peak lithium brine operation in the heart of Clayton Valley.
Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
By Pia Rivera
Bion Environmental Technologies, Inc. (OTCQB: BNET) announced that the Pennsylvania Clean Water Procurement Act (SB 799) was successfully voted out of the Pennsylvania Senate Environmental Resources and Energy Committee by a 10-2 vote.
By Pia Rivera
Invictus MD Strategies (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) Today, Invictus MD updated shareholders that it is taking steps to monitor the government policy development process in advance of the legalization of recreational cannabis that is expected in July 2018.
“There are a number of authorities across the
GoldQuest Mining Corp. (TSX VENTURE: GQC) (FRANKFURT: M1W) (BERLIN: M1W) (“GoldQuest” or the “Company”) is pleased to report assay results from the latest 8-drill hole batch from its Cachimbo Discovery, a Volcanogenic Massive Sulphide (VMS) deposit located within the Company’s 100% owned Tireo Concessions in the Dominican Republic. Cachimbo remains
Eastmain Resources Inc. (“Eastmain” or the “Company”) (TSX:ER)(OTCQX:EANRF) is pleased to announce the discovery of a high-grade gold-bearing vein system on the Éléonore South JV Property in the James Bay region of Québec. The discovery is the result of a continued focus within the property’s highly prospective exploration corridor since
By Jocelyn Aspa
Infinity Pharmaceuticals, Sorrento Therapeutics, CASI Pharmaceuticals, KalVista Pharmaceuticals, and Prima BioMed topped last week’s NASDAQ biotech stock list.
The gold price rose Friday after cooler-than-expected US inflation data and harsh words for Iran from US President Donald Trump.
By Jocelyn Aspa
Blockchain technology is on the rise, estimated to be worth 2.3 billion by 2021. Here’s a look at 7 public companies that are focused on the technology.
By Jocelyn Aspa
Sangoma Technologies (TSXV:STC) has announced highlights of its fourth quarter financial results for the full fiscal 2017 year ended June 30, 2017.
As quoted in the press release:
For the fourth quarter of fiscal 2017, sales were a record $7.68 million, 26% higher than the same quarter last year and 13% over
By Jocelyn Aspa
Criticism has surrounded the Cybersecurity Information Sharing Act since its bill passed in late 2015. Here’s a closer look at what the Act means, and what it looks like moving forward.
The gold price edged lower on Friday after a new jobs report increased worries of another rate hike from the US Federal Reserve.
At the halfway mark of 2017, here’s a look at how these four gene therapy companies are performing so far this year.
By Shelly Kumar
Golden Predator Mining Corp. (TSXV:GPY) (the “Company” or “Golden Predator“) is pleased to welcome William B. Harris and Richard Goldfarb, PhD, to its Board of Directors effective immediately.
“On behalf of the Board, management and our team, I am extremely pleased to welcome Bill and Rich to our Board of Directors. Having previously
By Shelly Kumar
FanDom Sports Media (CSE:FDM,OTCQB:FDMSF,Frankfurt:TQ42) (“FanDom Sports” or the “Company”) is pleased to announce the execution of their lead talent acquisition strategy. With the securing of contracts for key leadership roles within the company, FanDom Sports has acquired an experienced Head of Technology and a Lead Content Writer, both with extensive track
Zogenix, Aradigm, Vermillion, Aralez Pharmaceuticals and Kura Oncology top the NASDAQ biotech stock list.
The gold price has been driven mainly by geopolitical tensions and a weak US dollar in Q3, and looks set to end the period higher.
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
At a medical technology conference leaders in the medical device industry complained about the progress for the repeal of a 2.3 percent device tax.
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
